SynCore Biotechnology Co.,Ltd (TPEX:4192)
Taiwan · Delayed Price · Currency is TWD 20.00
+0.50 (2.56%)
May 29, 2026, 1:30 PM CST
TPEX:4192 Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -45.07 | -45.76 | -54.28 | -38.17 | -188.67 | -458.6 |
Depreciation & Amortization | 17.31 | 17.39 | 17.85 | 19.09 | 38.86 | 17 |
Other Amortization | 0.19 | 0.19 | 0.33 | 0.57 | 1.21 | 35.43 |
Loss (Gain) From Sale of Assets | -0.12 | -0.12 | -0.3 | - | 0.13 | - |
Loss (Gain) From Sale of Investments | 0.03 | - | - | - | - | - |
Provision & Write-off of Bad Debts | 0.06 | - | - | - | - | - |
Other Operating Activities | -0.07 | -0 | 0.01 | -60.41 | -0.06 | -0.06 |
Change in Accounts Receivable | -2.56 | -3.32 | 0.17 | -0.77 | 0.01 | -0.57 |
Change in Inventory | 4.03 | 0.38 | -6.93 | 14.36 | -0.3 | 0.67 |
Change in Accounts Payable | -8.96 | -8.26 | 9.32 | -0.32 | 0.32 | -11.4 |
Change in Unearned Revenue | 2.04 | 0.83 | - | - | - | - |
Change in Other Net Operating Assets | 1.87 | 0.33 | -15.4 | -16.73 | -61.11 | 187.67 |
Operating Cash Flow | -31.26 | -38.33 | -49.24 | -82.37 | -209.61 | -229.86 |
Capital Expenditures | -0.22 | -0.23 | -0.21 | -0.42 | -0.14 | -0.29 |
Sale of Property, Plant & Equipment | 0 | - | - | - | 0.01 | - |
Sale (Purchase) of Intangibles | -0.17 | -0.17 | -0.25 | -0.35 | -0.9 | -1.35 |
Investment in Securities | 0.54 | 0.54 | - | - | - | - |
Other Investing Activities | -0.39 | -0.39 | - | -0.02 | - | - |
Investing Cash Flow | -0.24 | -0.25 | -0.46 | -0.78 | -1.03 | -1.64 |
Long-Term Debt Issued | - | - | - | - | 30 | - |
Total Debt Issued | - | - | - | - | 30 | - |
Short-Term Debt Repaid | - | - | - | -60 | -60 | -60 |
Long-Term Debt Repaid | - | -9.63 | -9.51 | -10.61 | -43.21 | -43.19 |
Total Debt Repaid | -9.64 | -9.63 | -9.51 | -70.61 | -103.21 | -103.19 |
Net Debt Issued (Repaid) | -9.64 | -9.63 | -9.51 | -70.61 | -73.21 | -103.19 |
Issuance of Common Stock | - | - | - | 149.28 | - | 348.5 |
Financing Cash Flow | -9.64 | -9.63 | -9.51 | 78.68 | -73.21 | 245.31 |
Foreign Exchange Rate Adjustments | 0.02 | 0.06 | 0 | 0.03 | 0.03 | -0.08 |
Net Cash Flow | -41.12 | -48.15 | -59.21 | -4.45 | -283.83 | 13.74 |
Free Cash Flow | -31.48 | -38.57 | -49.45 | -82.79 | -209.75 | -230.15 |
Free Cash Flow Margin | -113.32% | -142.61% | -211.89% | -409.92% | -1322.74% | -3316.73% |
Free Cash Flow Per Share | -0.90 | -1.10 | -1.41 | -2.58 | -6.82 | -7.58 |
Cash Interest Paid | 0.17 | 0.17 | 0.3 | 0.81 | 2.31 | 2.1 |
Levered Free Cash Flow | -15.92 | -22.47 | -31.41 | -73.89 | -143.2 | -60.81 |
Unlevered Free Cash Flow | -15.82 | -22.37 | -31.22 | -73.4 | -141.78 | -59.54 |
Change in Working Capital | -3.58 | -10.04 | -12.85 | -3.45 | -61.08 | 176.37 |